Shelf life and expiration Compounded medications typically have shorter shelf lives than brand-name versions
After GLP-1related weight loss, concerns often shift from fat reduction to: Loose or crepey skin Changes in body shape Loss of definition or firmness This is where medical-grade skin tightening and body contouring come into play
American Journal of Epidemiology
Factors That May Affect Eligibility Certain conditions may preclude eligibility for specific medications
Over the two-year study period, patients receiving GLP-1based therapy experienced: Importantly, the study authors did not observe an increased risk for key diabetes-related complications, including diabetic ketoacidosis and hypoglycemia
The 28.328.7% average weight loss in TRIUMPH-1 and TRIUMPH-4, and the 2.0% HbA1c with 16.8% weight loss in TRANSCEND-T2D-1, are results no approved drug has matched